Meningococcal Vaccines Market Trends Analysis Report Products, By Application, By End Use, And Segment Forecasts

0
617

Market Forecast

Meningococcal Vaccines Market size is projected to be worth USD 6.80 billion by 2032, registering a CAGR of 7.3% during the forecast period 2023 – 2032.

The Meningococcal Vaccines Market is experiencing significant growth, driven by the rising incidence of meningococcal diseases globally. Meningococcal diseases, caused by the bacterium Neisseria meningitidis, can lead to serious illnesses such as meningitis and septicemia, posing a substantial public health burden. Increasing awareness about the importance of vaccination, coupled with government initiatives to incorporate meningococcal vaccines into routine immunization programs, is fueling market expansion. Additionally, advancements in vaccine technology, including the development of conjugate vaccines offering broader protection against multiple meningococcal serogroups, are further propelling market growth. Key players in the industry are investing in research and development to innovate new vaccine formulations with improved efficacy and safety profiles, catering to the evolving needs of healthcare systems worldwide.

The global market for meningococcal vaccines continues to witness significant growth, driven by increasing awareness about the prevention of meningococcal meningitis and infections. Meningococcal meningitis vaccine, a crucial component in the fight against meningococcal disease, plays a pivotal role in vaccination programs worldwide. This vaccine, designed to protect against the meningococcus bacterium, has emerged as a key preventive measure, particularly in regions prone to outbreaks. With rising incidences of meningococcal meningitis globally, fueled by factors such as population growth, urbanization, and international travel, the demand for effective vaccines remains robust. Pharmaceutical companies are actively engaged in the development and distribution of meningococcal meningitis vaccines, aiming to address the growing public health concern.

Moreover, the Meningococcal Vaccines Market is witnessing notable regional variations in demand and adoption rates, with developed regions showing higher uptake compared to developing economies. Factors such as vaccine affordability, accessibility, and healthcare infrastructure influence the distribution and utilization of meningococcal vaccines across different geographies. Collaborations between governments, non-profit organizations, and pharmaceutical companies are instrumental in expanding vaccine coverage, particularly in low- and middle-income countries where meningococcal diseases pose a significant public health challenge. Looking ahead, the market is poised for continued growth, driven by ongoing efforts to address unmet medical needs, expand vaccination coverage, and develop innovative vaccine formulations to combat meningococcal diseases effectively.

Key Players

The Meningococcal Vaccines Companies include:

  • Baxter international
  • Pfizer Inc.
  • Sanofi S.A.
  • Novartis Pharmaceuticals Inc.
  • JN-International Medical Corporation
  • Serum Institute of India Ltd.
  • GlaxoSmithKline
  • BIO-MED
  • OthersTop

Meningococcal Vaccines Market Segmentation

By treatment, the market is segmented into Meningococcal Conjugate Vaccine, Polysaccharide, Subcapsular Vaccine.

Meningococcal A conjugate vaccine is significantly used in mass campaigns across affected regions like Africa. Since 2010, the vaccine has significantly decreased meningococcal disease incidence in the region. However, the demand for meningococcal A conjugate in the country remains uncertain given that national immunization program adoptions are based on the timing of Gavi funding decisions, the country’s readiness, and competing for vaccine introduction priorities.

In the polysaccharide segment, products such as MenACWY vaccines are in high demand. MenACWY vaccine is the most desirable combination, given its broader serotype coverage. MenACWY specifically has nine products that are available across polysaccharide and conjugate product segments, but conjugate products are suggested for use in routine immunization activities.

Moreover, the demand and supply of Subcap MenB vaccines is restricted to HICs and influenced by their acceptance into NIPs. Improved uptake of MenB vaccines is expected in the coming years but will likely be moderate and limited to high-income markets given the high price and competing interest of introducing MenACWY conjugate.

By end-user, the market is segmented into Hospital & Clinical, Research Laboratories, and Academic Institutes

Hospitals and clinics control the global meningococcal vaccines market. The high growth of hospitals and clinics segment is attributed to the increasing application of vaccines in these healthcare facilities in conjunction with the growing prevalence and incidence of the meningococcal disease.

Moreover, research laboratories and academic institutes take up the second-largest share due to the boost in research and development in the market.

By region, the market is segmented into the Americas, Europe, Asia-Pacific, and the Middle East & Africa.

In the global market, China is expected to have the largest market share, which accounts for approximately 35% of the global demand. This is primarily due to polysaccharide products, which currently comprise 84% of China’s demand. Chinese suppliers presently focus only on meeting the demand of the domestic market, but some of the manufacturers have indicated interest in the global market as well. The dynamic product pipeline with several multivalent conjugate products in development may trigger changes in the future supply mix of the Chinese market. Moreover, in China, non-routine use (excluding campaigns) accounts for an estimated 9 million doses in 2019, which may help to sustain the huge market share in the forecast period.

Related Reports-

Neurorehabilitation Devices

Automated Cell Culture Equipment

body contouring marketing

Digital 3D Printing

Dental Chair

For more information, Please Visit us @ Market Research Future

Реклама
Поиск
Реклама
Категории
Больше
Бизнес
Concrete Floor Coating Market- Industry Size, Share, Trends (2023-2030)
Market Scope & Overview Readers of this report can do Concrete Floor Coating...
От Carry Bird 2023-10-26 06:05:31 0 917
Бизнес
Exploring the Future of the Smart Labels Market: Trends and Projections
In an era of rapid technological advancement, packaging is no longer just about enclosing a...
От Stephen Lobo 2023-10-20 08:06:10 0 942
Красота, здоровье
Bone Graft Substitute Market Share, Trends, Opportunities, Outlook & Forecast 2030
Bone Graft Substitutes Market Synopsis: Market Research Future (MRFR)’s latest study...
От Naina Deshmukh 2023-07-18 09:04:34 0 809
Литература
Tire Retreading Market Insights, Size, Trends, Industry Share, Growth Rate, Top Players, Business Opportunities, Demand, Forecast 2029
Tire Retreading Market was valued at US$ 3.77 Bn. in 2022. Global Tire Retreading Market size is...
От Sandip Jagtap 2024-01-05 07:25:17 0 1K
Бизнес
South Korea Maritime Security Market Regional Demand Overview (2024-2032)
South Korea Maritime Security Market The maritime security market in South Korea is undergoing...
От James Thomas 2024-06-07 10:18:06 0 306